Training activity information

Details

Analyse the appropriate genetic tests for circulating tumour referrals, to include:

  • NSCLC/EGFR

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

  • Prognostic and diagnostic genetic markers
  • Selection and analysis in mixed cell populations
  • Principles of the assays
  • Disease mechanism
  • Best practice guidance
  • Local and national guidance
  • Incidental findings
  • Quality control, including IQC, and EQA
  • Nomenclature
  • Sensitivity and limitations
  • Variant classification
  • Local SOPs
  • Health and safety
  • Follow up/reflex testing options

Relevant learning outcomes

# Outcome
# 4 Outcome

Analyse, interpret and report on genetic testing for circulating tumour referrals.